4//SEC Filing
RICKS THOMAS G 4
Accession 0001209191-23-042102
CIK 0001829802other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 5:02 PM ET
Size
8.8 KB
Accession
0001209191-23-042102
Insider Transaction Report
Form 4
RICKS THOMAS G
Director
Transactions
- Award
Common Stock
2023-07-10+4,466→ 8,932 total - Award
Stock Option (Right to Buy)
2023-07-10+14,550→ 14,550 totalExercise: $1.22Exp: 2033-07-09→ Common Stock (14,550 underlying)
Holdings
- 334,931(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
- [F2]These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and, accordingly, may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.
- [F3]The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001013023
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 5:02 PM ET
- Size
- 8.8 KB